Abstract: The invention is directed to a method of treating chronic spinal mechanical pain by intravenous administration to a subject in need of chronic spinal mechanical pain relief of an effective amount of bisphosphonate.
Abstract: Disclosed are systems for and methods of creating a synthetic image by registering a reference or atlas image to a clinical image using both rigid and deformable image registration algorithms. In some embodiments, a synthetic computed tomography (CT) image may be created by registering an atlas CT image to a clinical image such as an MR scan. Rigid registration in some embodiments may be followed by a smoothing B-spline transform algorithm with a mutual information similarity metric and an optimizer; followed then by an image signal intensity algorithm with displacement vectors at each voxel and diffeomorphic transformations.
Abstract: A controller for a battery charger that includes a power converter has parametric sensors for providing a sensed Vin signal, a sensed Vout signal and a sensed Iout signal. A battery current regulator (BCR) is coupled to receive the sensed Iout signal and an Iout reference, and outputs a first duty cycle control signal. An input voltage regulator (IVR) receives the sensed Vin signal and a Vin reference. The IVR provides a second duty cycle control signal. A processor receives the sensed Iout signal and utilizes a Maximum Power Point Tracking (MPPT) algorithm, and provides the Vin reference to the IVR. A selection block forwards one of the first and second duty cycle control signals as a duty cycle control signal to the power converter. Dynamic switching between the first and second duty cycle control signals maximizes the power delivered to the battery.
Type:
Grant
Filed:
March 4, 2011
Date of Patent:
July 8, 2014
Assignees:
University of Central Florida Research Foundation, Inc., Advanced Power Electronics Corporation (APECOR Corp.)
Inventors:
John Elmes, Rene Kersten, Michael Pepper
Abstract: The present invention relates to a dengue vaccine, a pharmaceutical composition comprising the same, a nucleotide sequence, and an antibody composition. The dengue vaccine of the present invention includes chimeric nonstructural protein 1, which comprises N-terminus of DV NS1 from amino-acid residues 1 to 270 and C-terminus of JEV NS1 from amino-acid residues 271 to 352 (designated DJ NS1). Therefore, the dengue vaccine without autoimmunity according to the present invention is able to avoid cross-reactions with endothelial cells and platelets, and is able to shorten the bleeding time.
Abstract: Provided is a thermal responsive molecule favorable as a thermal responsive low-molecular hydrogelling agent or the like that gels in response to heat. The thermal responsive molecule is characterized in that an amphiphilic side chain obtained by bonding a hydrophilic side chain such as triethylene glycol and a hydrophobic group such as an octyl group is introduced into a C3-symmetric disc-shaped molecular skeleton such as 1,3,5-benzenetriyltriurea. For example, the thermal responsive molecule is 1,1?,1?-(benzene-1,3,5-triyl)tris{3-(2,5,8,11-tetraoxaheptadecan-17-yl)urea} or the like.
Type:
Grant
Filed:
November 19, 2010
Date of Patent:
July 8, 2014
Assignee:
Kyushu University, National University Corporation
Abstract: A method and apparatus for a suture less injectable retinal detachment sponge and method for placing the sponge in a pocket beneath the surface of the sclera is the subject of the present invention. An exterior accessible pocket can be created in the sclera by making an incision in the outer surface. The incision can be made utilizing a crescent blade. The apparatus used to perform the procedure for insertion of the sponge in the pocket utilizes an injector having a cylinder and plunger combination. The cylinder can have a sponge removably contained therein and a plunger for injecting the sponge out of the cylinder portion of the injector to the desired location within the pocket.
Abstract: Methods and devices for stimulating nerves are disclosed. In one embodiment adapted for stimulating excitable tissue, the invention includes drive circuitry, an acoustic transducer and a pair of electrodes.
Type:
Grant
Filed:
December 3, 2012
Date of Patent:
July 8, 2014
Assignee:
Arizona Board of Regents on Behalf Arizona State University
Abstract: Microfluidic structures and methods for manipulating fluids and reactions are provided. Such structures and methods may involve positioning fluid samples, e.g., in the form of droplets, in a carrier fluid (e.g., an oil, which may be immiscible with the fluid sample) in predetermined regions in a microfluidic network. In some embodiments, positioning of the droplets can take place in the order in which they are introduced into the microfluidic network (e.g., sequentially) without significant physical contact between the droplets. Because of the little or no contact between the droplets, there may be little or no coalescence between the droplets. Accordingly, in some such embodiments, surfactants are not required in either the fluid sample or the carrier fluid to prevent coalescence of the droplets. Structures and methods described herein also enable droplets to be removed sequentially from the predetermined regions.
Abstract: Various embodiments of this invention relate generally to targeted activation and delivery of therapeutic drugs to cells that produce prostate specific antigen (PSA), prostate specific membrane antigen (PSMA) or human glandular kallikrein (hK2). Various further embodiments relate more specifically to PSMA-specific peptide prodrugs that become activated to yield therapeutic drugs. Further aspects of various embodiments of the present invention also relate to methods and compositions for treating or preventing cancers and methods and compositions for detecting and/or imaging cancers.
Type:
Grant
Filed:
March 17, 2010
Date of Patent:
July 8, 2014
Assignee:
The Johns Hopkins University
Inventors:
Samuel Ray Denmeade, John Tod Isaacs, Soeren Brogger Christensen
Abstract: The present invention relates to organic optoelectronic devices and, in particular, to organic photovoltaic devices having a fiber structure. In one embodiment, a photovoltaic device comprises a first electrode comprising an indium tin oxide fiber, at least one photosensitive organic layer surrounding the first electrode and electrically connected to the first electrode, and a second electrode surrounding the organic layer and electrically connected to the organic layer.
Type:
Grant
Filed:
May 1, 2007
Date of Patent:
July 8, 2014
Assignees:
Wake Forest University, Arrowhead Center, Inc.
Inventors:
Seamus A. Curran, David L. Carroll, James Lee Dewald, Sr.
Abstract: A spindle control system for a milling machine is provided. The milling machine includes a column, an overarm, a spindle for mounting a cutter, a first motor mounted on the column for driving movement of the overarm, and a second motor mounted on the overarm for driving rotation of the spindle. The spindle control system includes a distance sensor and a temperature sensor, each to be mounted on the overarm and to be disposed proximate to the end portion of the spindle. The spindle control system further includes a central control unit for determining a compensation parameter based on the displacement sensed by the distance sensor and the temperature sensed by the temperature sensor, and for controlling movement of the overarm by the first motor through a compensation distance based on the compensation parameter to compensate for at least one of the cutter deformation and the spindle deformation.
Type:
Grant
Filed:
May 18, 2011
Date of Patent:
July 8, 2014
Assignees:
Buffalo Machinery Company Limited, The Department of Electrical Engineering, National Chang-Hua University of Education
Abstract: Electrical connection systems and methods are disclosed. An electrical system includes an electrical plug and an electrical receptacle. The electrical plug has at least one prong having at least one opening. The electrical receptacle has at least one socket, an electrical contact positioned within the at least one socket, a light source positioned to transmit light through the at least one socket, and a photodetector positioned to receive the light transmitted by the light source through the at least one socket. The electrical receptacle further has a microprocessor programmed to selectively couple the electrical contact with the power source based on the light received by the photodetector.
Abstract: The present invention provides simple and rapid methods for measuring the function of a desired subset of lymphocytes, for example, T cells, B cells or NK cells. In addition, the present invention provides an all-in-one kit that contains reagents which permit a rapid and reliable analysis of the functions of T cells, B cells and NK cells obtained directly from whole blood or cord blood.
Type:
Grant
Filed:
July 30, 2007
Date of Patent:
July 8, 2014
Assignee:
The Research Foundation of State University of New York
Abstract: An apparatus and method for platelet multi-function analysis using measurement of electrical characteristics, and a stirring microchip are provided. The apparatus for platelet multi-function analysis includes a stirring microchip that has a sample storage chamber formed therein to hold a blood sample, and in which an inner part of the sample storage chamber is coated with reagents composed of collagen and epinephrine, or collagen and ADP. The apparatus for platelet multi-function analysis further includes a microstirrer installed inside the stirring microchip to stir the blood sample and the reagents in the stirring microchip and a stirring induction unit configured to facilitate stirring of the microstirrer. Therefore, the platelet aggregation and multi-function analysis can be performed using a trace of blood, and the platelet aggregation and multi-function analysis can also be performed using the whole blood taken from the veins through a vacuum tube containing an anticoagulant.
Type:
Grant
Filed:
August 31, 2012
Date of Patent:
July 8, 2014
Assignee:
Korea University Research and Business Foundation
Inventors:
Se Hyun Shin, Jeong Hun Nam, Hyun Jung Lim
Abstract: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.
Type:
Grant
Filed:
June 23, 2011
Date of Patent:
July 8, 2014
Assignees:
The Board of Trustees of the Leland Stanford Junior University, Department of Veterans Affairs
Inventors:
Lawrence Steinman, Shalina Sheryl Ousman, William H. Robinson
Abstract: A method of differentiating among the presence of ductal carcinoma in situ in the breast, benign fibroadenoma of the breast, and non-cancerous breast tissue in a subject is disclosed. The method involves measuring the concentration of at least one protein biomarker selected from a group of forty-nine differentially expressed proteins in the saliva of persons with DCIS, or benign fibroadenoma, or in persons who are cancer-free. The resulting test data is compared to a reference panel. From the comparison the presence in the subject of either ductal carcinoma in situ of the breast, or benign fibroadenoma of the breast is determined.
Type:
Grant
Filed:
June 14, 2013
Date of Patent:
July 8, 2014
Assignee:
Board of Regents of the University of Texas System
Inventors:
Charles F. Streckfus, William P. Dubinsky, Lenora R. Bigler
Abstract: Disclosed herein is a system and method for providing remotely accessible medical image data. The system and method allows for increased accuracy and semi-quantitative or fully quantitative data from images by enabling the remote user to select regions of interest on a compressed image, and then conducting quantitative analysis on original images at a central location.
Type:
Grant
Filed:
November 4, 2009
Date of Patent:
July 8, 2014
Assignee:
University of Central Florida Research Foundation, Inc.
Abstract: Novel stable, concentrated, biologically active and ready-to-use lipid-comprising drug delivery complexes and methods for their production are described. The biological activity of the complexes produced are comparable to the formulations prepared according to the prior art admixture method and upon purification, the complexes produced by the method of this invention are 50 to 500 fold more concentrated than the complexes formed by admixture. The method described herein provides for the large scale production of lipid-comprising drug delivery systems useful for gene therapy and other applications.
Type:
Grant
Filed:
December 12, 2012
Date of Patent:
July 8, 2014
Assignee:
University of Pittsburgh—Of the Commonwealth System of Higher Education
Abstract: Provided herein are methods for quantitating glutamate carboxypeptidase II activity in a biological sample, such as a skin biopsy sample, and for determining whether an agent is inhibiting GCP in a subject.
Type:
Grant
Filed:
January 5, 2012
Date of Patent:
July 8, 2014
Assignee:
The Johns Hopkins University
Inventors:
Barbara S. Slusher, Michael Polydefkis, Camilo Rojas, Marigo Stathis